Cargando…

PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE

Detalles Bibliográficos
Autores principales: Antipova, A., Baranova, O., Ibragimov, A., Petrova, G., Tumian, G., Osmanov, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430936/
http://dx.doi.org/10.1097/01.HS9.0000849880.24813.6c
_version_ 1784779914614931456
author Antipova, A.
Baranova, O.
Ibragimov, A.
Petrova, G.
Tumian, G.
Osmanov, E.
author_facet Antipova, A.
Baranova, O.
Ibragimov, A.
Petrova, G.
Tumian, G.
Osmanov, E.
author_sort Antipova, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9430936
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94309362022-08-31 PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE Antipova, A. Baranova, O. Ibragimov, A. Petrova, G. Tumian, G. Osmanov, E. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430936/ http://dx.doi.org/10.1097/01.HS9.0000849880.24813.6c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Antipova, A.
Baranova, O.
Ibragimov, A.
Petrova, G.
Tumian, G.
Osmanov, E.
PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title_full PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title_fullStr PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title_full_unstemmed PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title_short PB1756: INOTUZUMAB OZOGAMICIN IN THERAPY RELAPSE/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): A SINGLE CENTER EXPERIENCE
title_sort pb1756: inotuzumab ozogamicin in therapy relapse/refractory b-cell acute lymphoblastic leukemia (r/r b-all): a single center experience
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430936/
http://dx.doi.org/10.1097/01.HS9.0000849880.24813.6c
work_keys_str_mv AT antipovaa pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience
AT baranovao pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience
AT ibragimova pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience
AT petrovag pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience
AT tumiang pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience
AT osmanove pb1756inotuzumabozogamicinintherapyrelapserefractorybcellacutelymphoblasticleukemiarrballasinglecenterexperience